Palladium complexes of N‐heterocyclic carbenes as catalysts for cross‐coupling reactions—A synthetic chemist's perspective
EAB Kantchev, CJ O'Brien… - Angewandte Chemie …, 2007 - Wiley Online Library
Palladium‐catalyzed CC and CN bond‐forming reactions are among the most versatile
and powerful synthetic methods. For the last 15 years, N‐heterocyclic carbenes (NHCs) have …
and powerful synthetic methods. For the last 15 years, N‐heterocyclic carbenes (NHCs) have …
Three-dimensional printing of nanomaterial scaffolds for complex tissue regeneration
CM O'Brien, B Holmes, S Faucett… - Tissue Engineering Part …, 2015 - liebertpub.com
Three-dimensional (3D) printing has recently expanded in popularity, and become the
cutting edge of tissue engineering research. A growing emphasis from clinicians on patient-…
cutting edge of tissue engineering research. A growing emphasis from clinicians on patient-…
N-methyl-D-aspartate antagonists in the treatment of Parkinson's disease
JT Greenamyre, CF O'Brien - Archives of Neurology, 1991 - jamanetwork.com
• Current long-term treatment of Parkinson's disease is inadequate, and improved symptomatic
and neuroprotective therapies are needed. Recent interest has focused on the use of …
and neuroprotective therapies are needed. Recent interest has focused on the use of …
A decision support system for supplier selection using an integrated analytic hierarchy process and linear programming
SH Ghodsypour, C O'brien - International journal of production economics, 1998 - Elsevier
Supplier selection is a multicriteria problem which includes both qualitative and quantitative
factors. In order to select the best suppliers it is necessary to make a trade off between these …
factors. In order to select the best suppliers it is necessary to make a trade off between these …
Easily prepared air‐and moisture‐stable Pd–NHC (NHC= N‐heterocyclic carbene) complexes: a reliable, user‐friendly, highly active palladium precatalyst for the …
CJ O'Brien, EAB Kantchev, C Valente… - … A European Journal, 2006 - Wiley Online Library
The synthesis of NHC‐PdCl 2 ‐3‐chloropyridine (NHC=N‐heterocyclic carbene) complexes
from readily available starting materials in air is described. The 2,6‐diisopropylphenyl …
from readily available starting materials in air is described. The 2,6‐diisopropylphenyl …
Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo …
…, P Bardin, K Murphy, JF Maspero, C O'Brien… - The Lancet …, 2015 - thelancet.com
Background Elevated numbers of blood eosinophils are a risk factor for asthma exacerbations.
Reslizumab is a humanised anti-interleukin 5 monoclonal antibody that disrupts …
Reslizumab is a humanised anti-interleukin 5 monoclonal antibody that disrupts …
Systematic butchery by Plio/Pleistocene hominids at Olduvai Gorge, Tanzania [and comments and reply]
…, RG Klein, HM McHenry, CJ O'brien… - Current …, 1986 - journals.uchicago.edu
Human origins research by archaeologists has expanded the evidence of the diet and
subsistence activities of ancient hominids. We examine an important component of that evidence, …
subsistence activities of ancient hominids. We examine an important component of that evidence, …
[HTML][HTML] Ustekinumab as induction and maintenance therapy for ulcerative colitis
…, R Panaccione, CD O'Brien… - … England Journal of …, 2019 - Mass Medical Soc
Background The efficacy of ustekinumab, an antagonist of the p40 subunit of interleukin-12
and interleukin-23, as induction and maintenance therapy in patients with ulcerative colitis is …
and interleukin-23, as induction and maintenance therapy in patients with ulcerative colitis is …
[HTML][HTML] A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B
…, J Payne, JL Dienstag, C O'Brien… - … England Journal of …, 1990 - Mass Medical Soc
Background and Methods. Chronic hepatitis B is a common and often progressive liver disorder
for which there is no accepted therapy. To assess the efficacy of treatment with interferon…
for which there is no accepted therapy. To assess the efficacy of treatment with interferon…
Intensive voice treatment (LSVT®) for patients with Parkinson's disease: A 2 year follow up
…, S Countryman, AA Pawlas, C O'Brien… - Journal of Neurology …, 2001 - jnnp.bmj.com
OBJECTIVES To assess long term (24 months) effects of the Lee Silverman voice treatment (LSVT®),
a method designed to improve vocal function in patients with Parkinson's disease. …
a method designed to improve vocal function in patients with Parkinson's disease. …